OTLK

Outlook Therapeutics, Inc. [OTLK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

OTLK Stock Summary

Top 10 Correlated ETFs

OTLK


Top 10 Correlated Stocks

OTLK


In the News

01:01 29 Mar 2024 OTLK

All You Need to Know About Oncobiologics (OTLK) Rating Upgrade to Buy

Oncobiologics (OTLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

03:36 29 Mar 2024 OTLK

7 of the Best Speculative Stocks You Can Snag for Less Than $1

I'm about to drop a truth bomb about speculative stocks under $1. Back when I was a freshman in college, the on-campus security officer had this to say: “Tijuana?

01:37 29 Mar 2024 OTLK

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

While targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing matches the excitement of biotech penny stocks. Of course, the excitement goes toward both extremes of the emotional spectrum.

09:11 29 Mar 2024 OTLK

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Outlook (OTLK) stock rises after aligning with the FDA regarding the protocols of a non-inferiority study of ONS-5010 for AMD. The study is set to become the basis for BLA resubmission by 2024-end.

12:17 29 Mar 2024 OTLK

Best Penny Stocks To Buy Today? 3 To Watch This Week

Penny stocks, or “stocks under $5,” tend to occupy volatile territory with occasional meteoric runs. While savvy short-term traders eagerly scan for these explosive upside trades, penny stocks remain extremely high-risk.

02:12 29 Mar 2024 OTLK

Invest In Penny Stocks? Is It Worth It & 4 To Watch Now

If you're looking for penny stocks to invest in right now, you've got your work cut out for you. That's because the initial strategy when approaching cheap stocks is to trade them in the short term instead of holding them forever.

05:09 29 Mar 2024 OTLK

3 Penny Stocks To Buy According To Analysts, Targets Up To 365%

Penny stocks, defined as stocks trading under $5 per share, present traders and investors with opportunities for explosive returns. However, the penny stock territory also comes loaded with substantial risks.

02:11 29 Mar 2024 OTLK

5 Most Active Penny Stocks Today & Why They're Moving Now

Penny stocks are the wild west of the stock market. Fast-paced, unpredictable, and laden with potential treasures.

08:05 29 Mar 2024 OTLK

Outlook Therapeutics® to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology (INI) Conference

Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET

10:32 29 Mar 2024 OTLK

Best Penny Stocks Under $1? 4 To Watch This Week

What are the best penny stocks under $1? If you saw this headline, that's probably a question you have heading into the second half of the week.

OTLK Financial details

Company Rating
Sell
Market Cap
112.3M
Income
-51.5M
Revenue
0
Book val./share
-0.09
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
24
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-1502903.19
Forward P/E
-5.71
PEG
428610.85
P/S
-
P/B
-6449451.52
P/C
298.5
P/FCF
-2.25
Quick Ratio
0.5
Current Ratio
0.66
Debt / Equity
-1.5
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-2.09
EPS next Q
-0.94
EPS this Y
-22.58%
EPS next Y
935.77%
EPS next 5Y
-3577.4%
EPS last 5Y
-33.89%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-17.15%
-
-
-
-
SMA20
-2.2%
SMA50
12.65%
SMA100
-18.26%
Inst Own
9.36%
Inst Trans
0.83%
ROA
-192%
ROE
-3930%
ROC
3.68%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
13.01M
Shs Float
7.4M
-
-
-
-
Target Price
-
52W Range
4.0-40.6
52W High
-70.15%
52W Low
+198.5%
RSI
70.09
Rel Volume
9.46
Avg Volume
164.51K
Volume
1.56M
Perf Week
61.13%
Perf Month
41.97%
Perf Quarter
161.27%
Perf Half Y
171.36%
-
-
-
-
Beta
-0.003
-
-
Volatility
1.58%, 1.1%
Prev Close
27.43%
Price
11.94
Change
27.56%

OTLK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-30

Metric History 2019-09-302020-09-302021-09-302022-09-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.450000
Net income per share
-1.9-0.41-0.35-0.31-0.24
Operating cash flow per share
-1.77-0.37-0.36-0.27-0.17
Free cash flow per share
-1.8-0.37-0.36-0.27-0.17
Cash per share
0.440.150.090.080.09
Book value per share
-0.590.030.030.04-0.06
Tangible book value per share
-0.590.030.030.04-0.06
Share holders equity per share
-0.590.030.030.04-0.06
Interest debt per share
1.010.120.080.060.15
Market cap
542.12M1.23B6.63B5.17B1.11B
Enterprise value
549.05M1.23B6.62B5.17B1.12B
P/E ratio
-15.7-34.91-124.64-78.34-18.75
Price to sales ratio
66.550000
POCF ratio
-16.79-38.7-122.13-91.31-25.73
PFCF ratio
-16.56-38.7-122.13-91.31-25.73
P/B Ratio
-50.34435.331.44K592.31-76.59
PTB ratio
-50.34435.331.44K592.31-76.59
EV to sales
67.40000
Enterprise value over EBITDA
-25.34-33.78-127.93-82.15-21.25
EV to operating cash flow
-17-38.58-122.09-91.19-26.01
EV to free cash flow
-16.78-38.58-122.09-91.19-26.01
Earnings yield
-0.06-0.03-0.01-0.01-0.05
Free cash flow yield
-0.06-0.03-0.01-0.01-0.04
Debt to equity
-1.393.112.581.25-2.46
Debt to assets
0.870.450.520.381.1
Net debt to EBITDA
-0.320.10.050.1-0.23
Current ratio
0.671.133.191.390.66
Interest coverage
-10.47-20.98-55.26-42.4-34.06
Income quality
0.940.91.020.860.73
Dividend Yield
1.15K135.04000
Payout ratio
-18.1K-4.71K000
Sales general and administrative to revenue
1.150000
Research and developement to revenue
2.920000
Intangibles to total assets
00000
Capex to operating cash flow
0.010000
Capex to revenue
-0.050000
Capex to depreciation
-0.130000
Stock based compensation to revenue
0.160000
Graham number
5.030.550.490.540.55
ROIC
-4.27-2.13-3.11-3.2-2.52
Return on tangible assets
-2.01-1.79-2.33-2.32-1.83
Graham Net
-1.09-0.05-0.02-0.01-0.09
Working capital
-6.79M2.05M14.76M7.79M-15.75M
Tangible asset value
-10.77M2.83M4.61M8.74M-14.44M
Net current asset value
-14.4M1.04M3.3M7.73M-15.76M
Invested capital
-1.393.112.581.25-2.46
Average receivables
00000
Average payables
2.94M2.34M2.3M2.84M5.03M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
34.93K1.58K3.06K6.23K54.31K
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0.010.230.120.060.01
Inventory turnover
00000
ROE
3.21-12.47-11.54-7.564.09
Capex per share
-0.020000

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q1

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.1-0.03-0.08-0.05-0.04
Operating cash flow per share
-0.04-0.03-0.05-0.05-0.05
Free cash flow per share
-0.04-0.03-0.05-0.05-0.05
Cash per share
0.230.170.130.090.04
Book value per share
0.070.04-0.02-0.06-0.09
Tangible book value per share
0.070.04-0.02-0.06-0.09
Share holders equity per share
0.070.04-0.02-0.06-0.09
Interest debt per share
0.15-731.54-1.54K8.57K-724.82
Market cap
4.91B5.6B8.94B1.11B2.05B
Enterprise value
4.89B5.58B8.94B1.12B2.08B
P/E ratio
-56.75-210.22-108.1-21.28-45.87
Price to sales ratio
00000
POCF ratio
-551.84-689.54-676.4-86.79-157.37
PFCF ratio
-551.84-689.54-676.4-86.79-157.37
P/B Ratio
311.7533.5-1.62K-76.59-84.25
PTB ratio
311.7533.5-1.62K-76.59-84.25
EV to sales
00000
Enterprise value over EBITDA
-312.24-814.64-493.16-66.72-202.8
EV to operating cash flow
-549.54-688.09-676.48-87.74-159.38
EV to free cash flow
-549.54-688.09-676.48-87.74-159.38
Earnings yield
000-0.01-0.01
Free cash flow yield
000-0.01-0.01
Debt to equity
2.023.04-6.31-2.46-1.5
Debt to assets
0.510.590.781.11.69
Net debt to EBITDA
1.311.72-0.06-0.73-2.56
Current ratio
4.091.220.860.660.44
Interest coverage
-6.410000
Income quality
0.481.220.640.981.17
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.390.150.20.260.3
ROIC
-0.38-0.16-0.61-127.61-0.84
Return on tangible assets
-0.35-0.12-0.47-0.4-0.52
Graham Net
0.020-0.06-0.09-0.14
Working capital
46.59M9.52M-6.91M-15.75M-25.58M
Tangible asset value
15.76M10.49M-5.5M-14.44M-24.34M
Net current asset value
14.75M9.52M-6.93M-15.76M-25.64M
Invested capital
2.023.04-6.31-2.46-1.5
Average receivables
00000
Average payables
3.83M3.89M4.34M5.81M5.03M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
34.82K29.61K40.65K52.75K11.11K
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000.01
Inventory turnover
00000
ROE
-1.37-0.633.760.90.46
Capex per share
00000

OTLK Frequently Asked Questions

What is Outlook Therapeutics, Inc. stock symbol ?

Outlook Therapeutics, Inc. is a US stock , located in Iselin of Nj and trading under the symbol OTLK

What is Outlook Therapeutics, Inc. stock quote today ?

Outlook Therapeutics, Inc. stock price is $11.94 today.

Is Outlook Therapeutics, Inc. stock public?

Yes, Outlook Therapeutics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap